RBC Capital Starts Aptose Biosciences (APTO) at Outperform; Positive on CG-806
Tweet Send to a Friend
(Updated - March 1, 2019 6:30 AM EST)(updated to add analyst comments)RBC Capital analyst Gregory Renza initiates coverage on Aptose ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
